Evidence map›Paper›PMID 39403365›Full record

ArticleFrontiers in tuberculosis2024

Comorbidity profiles among sputum-positive tuberculosis patients in Cameroon.

Chefor Magha, Lucy Cho Nchang, Michael Weldeslassie, Desmond Akumtoh Nkimbeng, Nancielle Mbiatong Tchatat, Henry Dilonga Meriki, Kebede Deribe, Frank Noel Nietcho, Juluis Visnel Foyet, Fanny Fri Fombad and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in tuberculosis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Chefor MaghaParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Lucy Cho NchangParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Michael WeldeslassieDepartment of Biology, Mai Nefhi College of Science, Mai Nefhi, Eritrea.
Desmond Akumtoh NkimbengParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Nancielle Mbiatong TchatatParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Henry Dilonga MerikiParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Kebede DeribeChildren's Investment Fund Foundation, London, United Kingdom.
Frank Noel NietchoParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Juluis Visnel FoyetParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Fanny Fri FombadParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Tatiana Djikeussi KatchoParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Jerome Fru ChoParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Eyoab Iyasu GebremeskelDepartment of Biology, Mai Nefhi College of Science, Mai Nefhi, Eritrea.
Simon J WaddellDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
Kidist BoboshaArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Melanie J NewportDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
Achim HoeraufInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), Bonn, Germany.
Manuel RitterInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), Bonn, Germany.
Samuel WanjiParasites and Vector Research Unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.

Funding

European & Developing Countries Clinical Trials Partnership (EDCTP) TMA2019SFP-2814Wellcome Trust 201900
6 · The paper itself

Abstract

Introduction: Comorbid non-communicable diseases (NCDs) like diabetes, cardiovascular diseases (CVD), kidney diseases, and hypertension, could have implications for tuberculosis (TB) treatment management and increase the disease burden amongst active TB patients. Methods: This cross-sectional study aimed at profiling comorbidities amongst sputum-positive TB patients in the South West and Littoral regions of Cameroon and was relevant for improving disease management and public health interventions. Diabetes was defined by elevated blood glucose, body mass index (underweight: <18.5 kg/m Results: Five hundred and forty-nine sputum-positive microscopically confirmed active TB patients were enrolled into this study. Two-thirds (65.8%) of the total patients were male. Overall, 56 sputum-positive TB patients had at least one non-communicable disease, thus a prevalence of 10.2% (95% CI = 7.9-13.0). The most frequently recorded NCD was diabetes 4.4% (95% CI = 3.1-6.7) followed by kidney disease 2% (95% CI = 1.1-3.6), hypertension 0.9% (95% CI = 0.4-2.2), and CVD 0.91% (95% CI = 0.4-2.2). Three TB patients (0.6%) had all four comorbidities examined. Age group ( Discussion: Our findings showed that diabetes was significantly the most prevalent comorbid NCD amongst sputum-positive TB patients (

Indexed as

cardiovascular diseasecomorbiditiesdiabeteskidney diseaseMycobacterium tuberculosisnon-communicable diseasestuberculosis

Identifiers

PMID39403365
PMCPMC7616696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.